Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huabai Capsules
- Development stage
- Unknown
- Lead developer
- Lanzhou Foci
- Administration
- Oral
01
Overview
Huabai Capsules is a traditional Chinese medicine (TCM) developed and manufactured by Lanzhou Foci Pharmaceutical. It received a new TCM drug certificate in China in 2004. The formulation is specifically indicated for the treatment of chronic prostatitis, particularly cases categorized under the TCM syndrome of damp-heat stasis. Its therapeutic profile is characterized by the ability to clear heat, detoxify the body, promote diuresis to eliminate dampness, and resolve blood stasis. Clinically, it is used to alleviate symptoms such as urinary frequency, urgency, and localized pain associated with prostatic inflammation.
- Brand names
- Huabai Capsules花百胶囊
- Other names
- Huabai Jiaonang
Beyond the preview
Go deeper on Huabai Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huabai Capsules.